Medication info
Cosca Tablet 50 mg (Losartan Potassium)

Cosca Tablet 50 mg (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
SK Chemicals Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200803975 · Notified 2008.04.11 · Insurance code 644702820

Summary

Main use
Treatment of hypertension and nephropathy in patients with type 2 diabetes mellitus and hypertension
Who takes it
Adults · Children
Adult dose
This drug may be taken with or without food, but it is recommended to take it at the same time each day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is seen 3 ∼ 6 weeks after starting treatment. If the response is inadequate, the same dose may be given orally in two divided doses per day, or the dose may be increased to 100 mg once daily if necessary. If blood pressure is not controlled with this drug alone, it may be administered in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this drug once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be administered with insulin and commonly used hypoglycemic agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). No adjustment of the initial dose is necessary in elderly patients 75 years of age or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this drug once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this drug once daily is recommended. For patients who may have intravascular volume depletion (e.g., patients receiving diuretic therapy), an initial dose of 25 mg of this drug once daily is recommended (see Precautions for use). A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents aged 6 years or older who weigh 20 kg or more but less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this drug once daily; the dose may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years or older who weigh 50 kg or more: The usual recommended dose is 50 mg of this drug once daily; the dose may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Ingredients

Manufacturer
SK Chemicals Co., Ltd.

Efficacy & effects

Treatment of hypertension and nephropathy in patients with type 2 diabetes mellitus and hypertension

  • Hypertension
  • nephropathy in patients with type 2 diabetes
View approved original text

This medication is used to treat hypertension. It is also helpful in treating nephropathy in patients with type 2 diabetes and hypertension. This drug helps control blood pressure, reducing the risk of cardiovascular complications and contributing to the protection of kidney function. It improves various symptoms associated with hypertension, enhancing overall health.

How to take

Adult dose

This drug may be taken with or without food, but it is recommended to take it at the same time each day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is seen 3 ∼ 6 weeks after starting treatment. If the response is inadequate, the same dose may be given orally in two divided doses per day, or the dose may be increased to 100 mg once daily if necessary. If blood pressure is not controlled with this drug alone, it may be administered in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this drug once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be administered with insulin and commonly used hypoglycemic agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). No adjustment of the initial dose is necessary in elderly patients 75 years of age or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this drug once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this drug once daily is recommended. For patients who may have intravascular volume depletion (e.g., patients receiving diuretic therapy), an initial dose of 25 mg of this drug once daily is recommended (see Precautions for use). A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents aged 6 years or older who weigh 20 kg or more but less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this drug once daily; the dose may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years or older who weigh 50 kg or more: The usual recommended dose is 50 mg of this drug once daily; the dose may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Precautions

This drug may cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, and should be discontinued immediately upon confirmation of pregnancy. It is safest for women who may become pregnant to avoid using this drug. Patients with an allergy to this medication, severe liver dysfunction, or specific genetic lactose metabolism disorders should not take it. Elderly patients, those with impaired kidney function, very low blood pressure, or heart valve issues should take this medication under careful medical supervision. This drug may cause hyperkalemia, so patients with high potassium levels or those taking potassium supplements should be particularly cautious. If blood pressure drops too low, symptoms such as dizziness or fainting may occur, and any symptoms should be reported to a healthcare professional immediately. Rarely, serious side effects such as angioedema, hepatitis, renal failure, and skin rashes may occur, so any abnormal symptoms should be discussed with a specialist immediately. When taking this medication alongside other antihypertensives, diuretics, or non-steroidal anti-inflammatory drugs (NSAIDs), interactions may occur, so it is essential to inform your healthcare provider. Regular monitoring of blood pressure, blood tests, and kidney function tests is necessary during treatment, especially for women who are pregnant or planning pregnancy, who should consult their doctor before use. It is not recommended for children under 6 years of age, as safety and efficacy have not been established. This medication should be stored out of reach of children and in its original container without transferring to another.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • death
  • muscle spasms
  • low back pain
  • limb pain
  • dizziness
  • congestion
Show 124 more
  • upper respiratory tract infection
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • swelling
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm scaling
  • hemolytic phenomena
  • facial edema
  • fever
  • orthostatic effects
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscular rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory reduction
  • decreased libido
  • memory impairment
  • migraine
  • neural hypersensitivity
  • sensory disturbance
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • somnolence
  • tremor
  • shortness of breath
  • bronchitis
  • pharyngeal discomfort
  • nasal hemorrhage
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • alopecia
  • dermatitis
  • dry skin
  • petechial hemorrhage
  • erythema
  • flushing
  • photosensitivity reactions
  • itching
  • rash
  • sweating
  • urticaria
  • blurred vision
  • ocular burning
  • pain
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • vision impairment
  • erectile dysfunction
  • nocturia
  • frequent urination
  • urethral infection
  • vascular edema
  • vasculitis
  • anaphylactoid syndrome
  • liver function abnormalities
  • hepatitis
  • intestinal vascular edema
  • fatigue
  • thrombocytopenia
  • creatine kinase elevation
  • rhabdomyolysis
  • acute renal failure
  • dry cough
  • erythematous skin disease
  • hyponatremia
  • ALT elevation
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular extrasystole
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This drug may be sensitive to air or moisture, so it should be kept in a tightly sealed container. It is advisable to maintain storage temperatures between 1 to 30 degrees Celsius. Proper storage will ensure the safety and efficacy of the medication.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.